Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician

Author: Reddy Sujana   Kane Cecelia   Pitrosky Bruno   Musgnung Jeff   Ninan Philip T.   Guico-Pabia Christine J.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.26, Iss.1, 2010-01, pp. : 139-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content